Clinical Trial: A Study of Tazemetostat in Combination With HMPL-689 in Patients With Relapsed/Refractory Lymphoma
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Relapsed/Refractory Lymphoma
Study Type: INTERVENTIONAL
Official Title: A Phase II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Tazemetostat in Combination With HMPL-689 in Patients With Relapsed/Refractory Lymphoma
Brief Summary:
A phase II clinical study of tazemetostat combined with HMPL-689 in patients with R/R lymphoma.The study includes 2 phases: dose escalation phase (phase IIa) and expansion phase (phase IIb).
Read more